Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer
- 1 January 1996
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 3 (1) , 100-105
- https://doi.org/10.1007/bf02409059
Abstract
Background: The FAK gene encodes a 125-kDa tyrosine kinase (p125FAK) involved in signal transduction pathways used in cell adhesion, motility, and anchorage-independent growth. Because thyroid carcinomas have a wide variability in their propensity for invasion and metastasis, we studied the expression of FAK in a variety of thyroid tissues. Methods: We synthesized a recombinant N-terminal fragment of the human FAK protein and developed a specific polyclonal antisera. Using Western blot analysis, we assessed the levels of p125FAK expression in 30 human thyroid tissue samples from 27 patients that included paired normal and malignant specimens. Levels of FAK protein in individual tumors were quantitated by densitometric scanning of the immunoblots, and the results were correlated with tumor histology and biologic behavior. Results: The levels of FAK expression were directly correlated with thyroid carcinomas demonstrating the most aggressive phenotypes. The highest levels of p125FAK were seen in follicular carcinomas and tumors associated with distant metastatic foci. In contrast, neoplastic thyroid tissues with limited invasive potential, such as papillary carcinomas, follicular adenomas, and other nonmalignant thyroid lesions, showed minimal p125FAK expression. Conclusions: Overexpression of FAK may be part of a mechanism for invasion and metastasis of thyroid cancer. Furthermore, the levels of p125FAK may serve as a marker of biologic behavior in this disease.Keywords
This publication has 17 references indexed in Scilit:
- Approaches to the Treatment of High-Risk Thyroid CancerThyroid®, 1994
- Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumorsAnnals of Surgical Oncology, 1994
- High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.Journal of Clinical Investigation, 1993
- Focal adhesion kinase (p125FAK): A point of convergence in the action of neuropeptides, integrins, and oncogenesCell, 1992
- Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly.The Journal of cell biology, 1992
- Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformationNature, 1992
- pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions.Proceedings of the National Academy of Sciences, 1992
- Thyroid Cancer: A Lethal Endocrine NeoplasmAnnals of Internal Medicine, 1991
- Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomasBritish Journal of Cancer, 1988
- A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastasesNature, 1987